Velcade Followed By Thalidomide As Maintenance Therapy Yields Positive Initial ... The Myeloma Beacon All 45 patients received a stem cell transplant, and 40 subsequently started maintenance therapy. Within six to eight weeks of the transplant, patients received 1.3 mg/m 2 of Velcade on a weekly basis — that is, days 1, 8, and 15 of a 28-day cycle ... |
